Formulation Optimization and Stability Study of Transdermal Therapeutic System of Nicorandil
- 8 January 2002
- journal article
- Published by Taylor & Francis Ltd in Pharmaceutical Development and Technology
- Vol. 7 (3), 325-332
- https://doi.org/10.1081/pdt-120005729
Abstract
The aim of this research investigation was to fabricate acrylate-based stable transdermal therapeutic system (TTS) of nicorandil, which could deliver drug through transdermal route. Monolithic TTS was fabricated in pressure sensitive adhesives (PSAs)--(a) terpolymer (PSA1) of 2-ethylhexyl acrylate, methyl methacrylate, and acrylic acid, (b) copolymer (PSA2) of 2-ethylhexyl acrylate, methyl methacrylate, acrylic acid, and vinyl acetate, and (c) Eudragit E100 pressure sensitive adhesive (PSA3). To enhance the flux of nicorandil, skin permeation enhancer N-methyl-2-pyrrolidone (NMP) was investigated at different concentrations (0.05-5%) in PSAs. Fabricated TTS was evaluated for in-vitro release and skin permeation through guinea pig skin. Maximum flux of nicorandil was observed from Eudragit E100 based TTS and kept for stability study at refrigeration, 25 degrees C/30% RH and 30 degrees C/60% RH. Patches were evaluated for various physicochemical parameters. Formulation was observed to be relatively more stable at refrigeration. Shelf life of the formulation was found to be 270, 270, and 30 days at refrigeration, 25 degrees C/30% RH and 30 degrees C/60% RH conditions, respectively. Nicorandil could be successfully derived from Eudragit E100 based TTS, but attention needs to be given to improve its chemical stability in formulation.Keywords
This publication has 12 references indexed in Scilit:
- Acrylate terpolymer in fabrication of medicated skin patchesPolymers for Advanced Technologies, 2001
- High-performance liquid chromatographic method for stability and pharmacokinetic studies of nicorandilJournal of Chromatography B: Biomedical Sciences and Applications, 1993
- NicorandilDrugs, 1992
- Enhancing effect of pyrrolidone derivatives on transdermal drug delivery II. Effect of application concentration and pre-treatment of enhancerInternational Journal of Pharmaceutics, 1990
- Pharmacokinetics of nicorandilThe American Journal of Cardiology, 1989
- Prediction of the In-vitro Human Skin Permeability of Nicorandil from Animal DataJournal of Pharmacy and Pharmacology, 1989
- Drug permeation through skin from matrix-type drug delivery systemsThe Chemical Engineering Journal, 1986
- Drug delivery systemsPharmacology & Therapeutics, 1981
- The Accelerant Effect of N-Methyl-Pyrrolidone for Penetration of the Model Compound [14C] Mannitol into Cadaver Human Skin, A Transient EffectJournal of Pharmacy and Pharmacology, 1981
- Diffusion Model for Drug Release from Suspensions I: Theoretical ConsiderationsJournal of Pharmaceutical Sciences, 1977